Answers are grounded in this paper and cite their sources.
Since 2017, the clinical value of podocyte injury in IgA nephropathy(IgAN) has been studied, the presence of podocyte hypertrophy and tip- lesions are markers of podocyte damage. It has been observed that these histological findings tend to be treated with immunosuppression, so they have a better kidney prognosis, but those who do not receive inmunsuppression have a worse prognosis. In Latin America there are no cohorts that evaluate the clinical course of these lesions.
No takes yet. Share an insight, caveat, or question.
VAZQUEZ et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: